ASPIRO FDA Approval ANDA 214336

ANDA 214336

ASPIRO

FDA Drug Application

Application #214336

Application Sponsors

ANDA 214336ASPIRO

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTION1%0LIDOCAINE HYDROCHLORIDELIDOCAINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2021-11-08STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAP

CDER Filings

ASPIRO
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214336
            [companyName] => ASPIRO
            [docInserts] => ["",""]
            [products] => [{"drugName":"LIDOCAINE HYDROCHLORIDE","activeIngredients":"LIDOCAINE HYDROCHLORIDE","strength":"1%","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"11\/08\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-11-08
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.